Also known as: Lysine-Proline-Valine
KPV, or Lysine-Proline-Valine, is a tripeptide that falls under the category of Immunomodulation Peptides. It is composed of three amino acids and is primarily recognized for its anti-inflammatory properties. KPV has garnered attention in the field of research due to its potential applications in modulating immune responses and reducing inflammation.
This peptide is naturally occurring in the body and is derived from the alpha-melanocyte-stimulating hormone (α-MSH). Its structure allows it to interact with various biological pathways, making it a subject of interest for researchers exploring therapeutic avenues in inflammation-related conditions.
KPV exerts its effects primarily through its interaction with immune cells. By binding to specific receptors, it can modulate the activity of these cells, leading to a reduction in inflammatory responses.
The peptide influences the production of pro-inflammatory cytokines, which are signaling molecules that can exacerbate inflammation. By inhibiting these cytokines, KPV helps to maintain a balanced immune response, promoting healing and reducing tissue damage associated with chronic inflammation.
KPV is a tripeptide with significant anti-inflammatory properties, making it relevant in the study of immune modulation. Its ability to influence inflammatory pathways positions it as a valuable compound in research aimed at treating various inflammatory conditions.
Last updated: Feb 25, 2026